OPEN END TURBO PUT WARRANT - ELI LILLY & CO | Market Closed - Boerse Frankfurt Warrants 01:40:44 2024-07-17 pm EDT | ||
| 15.82 EUR | +20.12% |
|
| Current month | -4.70% | ||
| 1 month | -15.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 15.82 | +20.12% |
| 24-07-16 | 13.17 | +2.81% |
| 24-07-15 | 12.81 | -1.39% |
| 24-07-12 | 12.99 | -12.99% |
| 24-07-11 | 14.93 | +7.64% |
Real-time Boerse Frankfurt Warrants
Last update July 17, 2024 at 01:40 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | UBS |
| WKN | UM2DZD |
| ISIN | DE000UM2DZD0 |
| Date issued | 2024-02-07 |
| Strike | 1,089 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 35.81 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 35.67 € |
|---|---|
| Lowest since issue | 11.39 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
941.6
USD
Average target price
901.5
USD
Spread / Average Target
-4.26%
- Stock Market
- Certificates
- Certificat
